Bridgewater Associates’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-738
Closed -$221K 748
2021
Q1
$221K Buy
+738
New +$221K ﹤0.01% 440